Start of a formal collaboration with Bit Bio (Cambridge) and LIMS (London) on the mathematical modellling of cell reprogramming
Replica analysis of overfitting in generalized linear models (Coolen et al, submitted to Journal of Physics A)
HER2-HER3 heterodimer quantification by FRET-FLIM and patient subclass analysis of the COIN colorectal trial (Barber et al, Journal of the National Cancer Institute)
Analysis of overfitting in the regularized Cox model (Sheikh and Coolen, Journal of Physics A)
Accurate Bayesian data classification without hyperparameter cross-validation (Sheikh and Coolen, Journal of Classification)
The SaddlePoint Signature analytics pipeline is installed at Erasmus Medical Center Rotterdam (Dept of Epidemiology).
Heterogeneity in risk of prostate cancer: A Swedish population-based cohort study of competing risks and Type 2 diabetes mellitus (Haggstrom et al, Int J Cancer)
the EU consortium RGS@home, in which SaddlePoint Science is the analytics partner, has been awarded an EIT Health grant (ranked 2nd out of 175 applications). RGS@home will start early 2019.